130 related articles for article (PubMed ID: 36473713)
1. Development of pharmacophore model to identify potential DNA gyrase inhibitors.
Jakhar R; Khichi A; Kumar D; Sura K; Bhoomika ; Dangi M; Chhillar AK
J Biomol Struct Dyn; 2023 Nov; 41(19):10125-10135. PubMed ID: 36473713
[TBL] [Abstract][Full Text] [Related]
2. Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches.
Kalhor H; Sadeghi S; Marashiyan M; Kalhor R; Aghaei Gharehbolagh S; Akbari Eidgahi MR; Rahimi H
J Biomol Struct Dyn; 2020 Feb; 38(3):791-806. PubMed ID: 30916622
[TBL] [Abstract][Full Text] [Related]
3. Identification of promising anti-DNA gyrase antibacterial compounds using
Islam MA; Pillay TS
J Biomol Struct Dyn; 2020 Apr; 38(6):1798-1809. PubMed ID: 31084271
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
Azam MA; Thathan J
SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
[TBL] [Abstract][Full Text] [Related]
5. Identification of apigenin-4'-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies.
Harini M; Kavitha K; Prabakaran V; Krithika A; Dinesh S; Rajalakshmi A; Suresh G; Puvanakrishnan R; Ramesh B
J Mol Model; 2024 Jan; 30(1):22. PubMed ID: 38170229
[TBL] [Abstract][Full Text] [Related]
6. Identification of promising DNA GyrB inhibitors for Tuberculosis using pharmacophore-based virtual screening, molecular docking and molecular dynamics studies.
Islam MA; Pillay TS
Chem Biol Drug Des; 2017 Aug; 90(2):282-296. PubMed ID: 28109130
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
[TBL] [Abstract][Full Text] [Related]
8. In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.
Kashyap A; Singh PK; Silakari O
Tuberculosis (Edinb); 2018 Sep; 112():83-88. PubMed ID: 30205973
[TBL] [Abstract][Full Text] [Related]
9. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Inhibitors of Bacterial DNA Gyrase Using a QSAR-Based Approach.
Jakhar R; Khichi A; Kumar D; Dangi M; Chhillar AK
ACS Omega; 2022 Sep; 7(36):32665-32678. PubMed ID: 36120069
[TBL] [Abstract][Full Text] [Related]
11. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
[TBL] [Abstract][Full Text] [Related]
12.
Roney M; Issahaku AR; Forid MS; Huq AKMM; Soliman MES; Mohd Aluwi MFF; Tajuddin SN
J Biomol Struct Dyn; 2023; 41(24):14904-14913. PubMed ID: 36995164
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH.
Yang YS; Su MM; Xu JF; Liu QX; Bai LF; Hu XW; Zhu HL
Bioorg Chem; 2019 Dec; 93():103309. PubMed ID: 31585266
[TBL] [Abstract][Full Text] [Related]
14. Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing.
Metelytsia L; Hodyna D; Dobrodub I; Semenyuta I; Zavhorodnii M; Blagodatny V; Kovalishyn V; Brazhko O
Comput Biol Chem; 2020 Apr; 85():107224. PubMed ID: 32018168
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine-Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors.
Mohi El-Deen EM; Abd El-Meguid EA; Hasabelnaby S; Karam EA; Nossier ES
Molecules; 2019 Oct; 24(20):. PubMed ID: 31658631
[TBL] [Abstract][Full Text] [Related]
17. Docking and 3D QSAR Studies on Substituted Cyclobutylphenyl Quinoline Derivatives as Inhibitors of Bacterial DNA Gyrase.
Wani RR; Chaudhari HK
Curr Comput Aided Drug Des; 2018; 14(4):322-337. PubMed ID: 29766821
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors.
Mohammed HHH; Ali DME; Badr M; Habib AGK; Mahmoud AM; Farhan SM; Gany SSHAE; Mohamad SA; Hayallah AM; Abbas SH; Abuo-Rahma GEA
Mol Divers; 2023 Aug; 27(4):1751-1765. PubMed ID: 36152132
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
Nastasă C; Vodnar DC; Ionuţ I; Stana A; Benedec D; Tamaian R; Oniga O; Tiperciuc B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
